LL-37 Induces Apoptosis in Leukemia Cells through a Caspase-Independent Mechanism

Scientists in Edmonton, Canada have discovered that LL-37, a human cationic host defense peptide, can kill Jurkat T leukemia cells through apoptosis, a process of programmed cell death. The researchers, led by J.S. Mader and colleagues from the University of Alberta, found that LL-37-induced apoptosis was mediated through a mitochondria-associated pathway, independent of caspase family members. The study, published in Molecular Cancer Research, showed that the specific apoptotic pathway induced by LL-37 involved the transfer of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus of cells, leading to DNA fragmentation and chromatin condensation.

Key Takeaways:

• LL-37, a human cationic host defense peptide, can induce apoptosis in Jurkat T leukemia cells through a caspase-independent mechanism.
• The apoptotic pathway induced by LL-37 is mediated through a mitochondria-associated pathway, involving the transfer of AIF from the mitochondria to the nucleus.
• AIF knockdown analysis revealed that AIF is mandatory in LL-37-mediated killing.
• Calpains are required for LL-37-mediated Bax translocation to mitochondria.
• LL-37-induced apoptosis involves Bax activation and translocation to mitochondria.
• The study suggests that LL-37 could be a potential therapeutic agent for cancer treatment, targeting leukemia cells through apoptosis.

Statistics:

• 7(5):689-702 (volume and page numbers of the published study).
• 2009 (year of publication).
• 100% reduction in LL-37-induced apoptosis in Bcl-2-overexpressing cells.
• 50% reduction in LL-37-induced apoptosis in cells deficient in Bax and Bak proteins.
• 70% inhibition of LL-37-mediated apoptotic killing in AIF knockdown cells.

Sources:

Mader, J.S., et al. (2009). The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity. Molecular Cancer Research, 7(5), 689-702.